ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,790.13
-0.43%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Fennec Pharmaceuticals Inc (FRX)

  7. Fennec Pharmaceuticals Inc (FRX) News

FRX

Fennec Pharmaceuticals (FRX)

Fennec Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:FRX
DateTimeSourceHeadlineSymbolCompany
18/03/202418:00PR Newswire (US)Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandTSX:FRXFennec Pharmaceuticals Inc
14/09/201702:39PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - FRXTSX:FRXFennec Pharmaceuticals Inc
14/09/201702:35PR Newswire (Canada)IIROC Trade Resumption - FRXTSX:FRXFennec Pharmaceuticals Inc
13/09/201723:32PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - FRXTSX:FRXFennec Pharmaceuticals Inc
13/09/201723:29PR Newswire (Canada)IIROC Trading Halt - FRXTSX:FRXFennec Pharmaceuticals Inc
02/06/201501:00PR Newswire (US)Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual MeetingTSX:FRXFennec Pharmaceuticals Inc
28/08/200908:31PR Newswire (US)Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and ReduceASX:FRX
10/08/200921:00PR Newswire (US)Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPDASX:FRX
22/06/200923:20PR Newswire (US)Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and WyndhamASX:FRX
21/05/200801:30PR Newswire (US)Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic fASX:FRX
09/11/200700:30PR Newswire (US)Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data ShowASX:FRX
02/05/200701:49PR Newswire (US)Response Submitted to FDA Approvable Letter for Hypertension Compound NebivololASX:FRX
16/02/200610:07PR Newswire (US)/C O R R E C T I O N -- Forest Laboratories, Inc./ASX:FRX
 Showing the most relevant articles for your search:TSX:FRX

Your Recent History

USOTC
PTRC
Petro River Oil (CE)
TIDE
BTGUSDT
NASDAQ
GEHL
Gehl
EU
5403T
5403T
NASDAQ
GPACU
Global Partner Acqusitio...
BIT
PSRW
Invesco FTSE RAFI All Wo...
NASDAQ
FWDZTX
High Yield Income Closed...
USOTC
PERL
Perla (CE)
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved